Filing Details

Accession Number:
0000899243-20-019186
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-15 17:11:41
Reporting Period:
2020-07-13
Accepted Time:
2020-07-15 17:11:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1629137 Global Blood Therapeutics Inc. GBT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1405253 S Jeffrey Farrow C/O Global Blood Therapeutics, Inc.
181 Oyster Point Boulevard
South San Francisco CA 94080
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-07-13 15,208 $75.00 3,048 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2020.